Robert Valdes, Carey ’06
Biotech Resources Group, LLC / InnoAsia, Co. Ltd
Robert Valdes (Bob) has over 25 years of experience in the GMP Manufacturing sector and currently serves as co-founder and GMP Consultant at Biotech Resources Group (USA) and INNOASIA Ltd. (Joint-Venture in Hangzhou, PRC).
Prior to this start-up, Bob served as the Director, Large-Scale Manufacturing at Human Genome Sciences (acquired by GSK) where he oversaw the manufacture of Human Genome’s first commercial product Benlysta®, the first lupus drug to make it through US regulators in more than half a century. Prior to his 12-year tenure at Human Genome Sciences, he was employed by Lonza Biologics (US/UK) from 1994 to 2000 in various positions in biologics manufacturing, design, and engineering. Bob’s first awesome biotech job out of school was at Charm Sciences Inc. as a pilot-plant microbiologist.
As a strong community citizen, Bob founded and operated RRMS Inc. for 12 years. RRMS was a nonprofit (501c3) benefiting the Multiple Sclerosis community in over 20 states. From 2009-2016, Bob also served on the Johns Hopkins Carey Business School’s Alumni Board (DAAB) whose primary goal is to encourage global alumni participation and engagement.
Bob lives in Gaithersburg, MD with his wife Susie and enjoys cycling, hockey, karate, and traveling. Originally from the northeast, Mr. Valdes and his wife Susie have lived in Maryland for almost 20 years. Mr. Valdes holds Masters degrees from the University of Massachusetts (MSc) and Johns Hopkins Carey Business School. An avid reader and learner, Bob is focused on international business analytics and building innovation capital for his next venture.